![]() Upon NRC license amendment approval and successful completion of the NRC’s Operational Readiness Review, Centrus expects to begin HALEU production by early 2022.Auxiliary and support systems necessary for operation of the cascade are being installed. Design and engineering work on the non-centrifuge or “balance of plant” systems is near completion and system construction is well under way.The centrifuges will undergo final preparations prior to being installed into the production cascade. This month, Centrus completed assembly of all AC100M gas centrifuges.facility licensed for the full range of LEU and HALEU production up to 20 percent U-235. The facility has an existing NRC license for production up to 10 percent and, if this amendment is approved, will become the first U.S. The NRC has accepted the LAR for technical review and that review is under way. Nuclear Regulatory Commission (NRC) last year to modify its commercial license so that it can enrich uranium up to 20 percent U-235. Centrus submitted a license amendment request (LAR) to the U.S. ![]() HALEU, which is enriched so that the concentration of the U-235 isotope is higher than the 4-5 percent level typically used in existing reactors but lower than 20 percent, offers numerous advantages in reactor performance and a lower volume of waste produced. For example, 9 out of the 10 reactor designs selected by the Department of Energy for its Advanced Reactor Demonstration Program are expected to operate on HALEU. HALEU is an advanced nuclear fuel material that is not commercially available in the United States today, but may be required in the future to fuel both existing and next generation reactors. The Department stated the objective was to demonstrate a domestic technology so that it “could be used in any type of advanced reactors, including defense reactors that require the use of HALEU produced using U.S.- origin technology.” The three year, $115 million, cost-shared contract runs through mid-2022. technology – to demonstrate production of HALEU. Department of Energy’s Office of Nuclear Energy, Centrus is licensing and constructing a cascade of sixteen AC100M centrifuges – a U.S. “We believe this first-of-a-kind facility can play a critical role in meeting both government and commercial requirements for HALEU, powering America’s nuclear leadership as the world turns to a new generation of advanced reactors and advanced nuclear fuels.” “Despite the impact of the pandemic and the extraordinary steps we have taken to protect our workforce – including limiting the number of people who can be on the construction site at any one time – we have kept construction on track and expect to begin producing HALEU by next year,” said Centrus President and CEO Daniel B. (NYSE American: LEU) is providing an update on construction of the nation’s first production facility for High-Assay, Low-Enriched Uranium (HALEU) in Piketon, Ohio. Production of High-Assay, Low-Enriched Uranium (HALEU) Expected to Begin by Early 2022īETHESDA, Md.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |